Helping people get the medicine
they need.

Prime Therapeutics helps people get the medicine they need to feel better and live well.

We manage coverage for medicine to health insurers, employers, seniors on Medicare and individuals. We process claims and deliver medicine to our members, and we offer clinical services for people with complex medical conditions such as cancer.

Prime is owned by 13 not-for-profit Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. This unique ownership structure makes it possible for us to remain absolutely committed to the health of the members we serve.

Our employees are devoted to providing the more than 25 million members we serve with the best possible customer experience. We have a unique culture where employees truly want to help people live healthier lives.

The proof of our success is in our growth. We're one of the fastest growing companies in America.

Recent News

Prime Therapeutics responds to FDA approval of Gilead's latest Hepatitis C drug (October 10, 2014)

Duane Barnes, Prime Therapeutics' COO, joins NASP / SPAARx board of directors (October 9, 2014)

Prime Therapeutics, Johns Hopkins publish research on specialty drug copay coupons in "Health Affairs" (October 6, 2014)

Blue Cross Blue Shield Association and Prime Therapeutics study demonstrates health benefits and cost savings of pharmacy benefit integration within insurance plans (October 6, 2014)

Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs (September 30, 2014)

Prime Therapeutics' Wickersham delivers keynote at Managed Markets Summit (September 17, 2014)